U.S. market Closed. Opens in 2 days 4 hours 18 minutes

ARQT | Arcutis Biotherapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue59.61M3.69MN/AN/AN/AN/AN/A
Cost of Revenue6.12M754.00K763.00K455.00K195.00KN/AN/A
Gross Profit53.49M2.93M-763.00K-455.00K-195.00KN/AN/A
Operating Expenses294.59M304.56M206.53M136.65M43.13M19.73M4.11M
Selling, General & Admin184.01M122.12M60.97M21.34M6.61M1.79M695.00K
Research & Development110.58M182.44M145.56M115.31M36.52M17.94M3.41M
Other Operating Expenses11.79M5.82M173.00K967.00K1.14M480.00KN/A
Operating Income-241.10M-301.63M-206.53M-136.65M-43.13M-19.73M-4.11M
Other Expenses / Income-17.93M-9.83M173.00K967.00K1.14M480.00K-872.00K
Before Tax Income-259.03M-311.46M-206.36M-135.68M-42.00M-19.25M-4.98M
Income Tax Expenses3.11M9.83M-454.00K-84.30K23.14K-480.00KN/A
Net Income-262.14M-321.29M-205.90M-135.68M-42.00M-19.25M-4.98M
Interest Expenses29.71M15.65MN/AN/AN/AN/AN/A
Basic Shares Outstanding69.31M55.03M49.41M35.67M38.09M18.04M18.04M
Diluted Shares Outstanding69.31M55.03M49.41M35.67M38.09M18.04M18.04M
EBITDA-239.22M-295.81M-206.53M-136.52M-42.94M-19.73M-4.98M
EBITDA Margin-401.34%-8,025.12%0.00%0.00%0.00%0.00%0.00%
EBIT-229.31M-295.81M-206.36M-135.76M-41.97M-19.73M-4.98M
EBIT Margin-384.72%-8,025.12%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙